Complementing clinical cancer registry data with patient reported outcomes: A feasibility study on routine electronic patient-reported outcome assessment for the Austrian Myelome Registry

被引:15
|
作者
Sztankay, Monika [1 ,2 ,3 ]
Neppl, Lucia [2 ]
Wintner, Lisa M. [1 ,3 ]
Loth, Fanny L. [2 ]
Willenbacher, Wolfgang [4 ,5 ]
Weger, Roman [5 ]
Weyrer, Walpurga [4 ]
Steurer, Michael [4 ]
Rumpold, Gerhard [1 ]
Holzner, Bernhard [1 ,2 ]
机构
[1] Med Univ Innsbruck, Innsbruck, Tirol, Austria
[2] Univ Innsbruck Hosp, Psychiat 2, Anichstr 35, A-6020 Innsbruck, Tirol, Austria
[3] Univ Innsbruck, Innsbruck, Tirol, Austria
[4] Univ Innsbruck Hosp, Internal Med Haematol & Oncol 5, Innsbruck, Tirol, Austria
[5] Oncotyrol Ctr Personalized Canc Med, Innsbruck, Tirol, Austria
基金
奥地利科学基金会;
关键词
cancer registry; clinical routine; electronic patient-reported outcome monitoring; health-related quality of life; implementation; multiple myeloma; QUALITY; CARE; SURVEILLANCE; RATIONALE; SYMPTOMS; TRIALS;
D O I
10.1111/ecc.13154
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Objectives Routinely assessed patient-reported outcomes (PROs), such as quality of life (QOL), are important to supplement clinical cancer data but requires rigorous implementation. This study aims at depicting the implementation procedure and evaluating the feasibility of routine electronic PRO monitoring (ePRO) for collecting data supplementing the Austrian Myeloma Registry (AMR). Methods Integration of ePRO monitoring into clinical routine was planned according to the Replicating Effective Programs framework. QOL data were assessed regularly during treatment and aftercare at the hematooncological outpatient unit at the Medical University of Innsbruck with the EORTC QLQ-C30/ +MY20 and the EQ-5D-5L. Feasibility and usability testing were performed via a multimethod approach. Results Within the first year, 94.4% of the MM patients (N = 142, mean age 65.4, SD 11.8, 60% male) provided 748 PRO assessment time points overall. Patients and clinicians were satisfied with ePRO monitoring and indicated no to little disruption in clinical routine. Patient preference on assessment time points and completion frequency became evident. Conclusions Complementing the AMR with ePRO data proved to be feasible. Our findings provide useful insights for healthcare providers considering introducing ePRO monitoring to their units for informing clinical registries as well as individualised feedback to patients alike.
引用
收藏
页数:12
相关论文
共 50 条
  • [1] Complementing clinical cancer registries with patient-reported outcome data - a feasibility study on routine ePRO assessment for the Austrian Myeloma Registry
    Sztankay, Monika
    Neppl, Lucia
    Wintner, Lisa
    Rumpold, Gerhard
    Weger, Roman
    Willenbacher, Wolfgang
    Weyrer, Walpurga
    Steurer, Michael
    Holzner, Bernhard
    QUALITY OF LIFE RESEARCH, 2018, 27 : S101 - S101
  • [2] Integrating Patient Reported Outcomes With Clinical Cancer Registry Data: A Feasibility Study of the Electronic Patient-Reported Outcomes From Cancer Survivors (ePOCS) System
    Ashley, Laura
    Jones, Helen
    Thomas, James
    Newsham, Alex
    Downing, Amy
    Morris, Eva
    Brown, Julia
    Velikova, Galina
    Forman, David
    Wright, Penny
    JOURNAL OF MEDICAL INTERNET RESEARCH, 2013, 15 (10) : 178 - 196
  • [3] Adding Centralized Electronic Patient-Reported Outcome Data Collection to an Established International Clinical Outcomes Registry
    Cusatis, Rachel
    Flynn, Kathryn E.
    Vasu, Sumithira
    Pidala, Joseph
    Muffly, Lori
    Uberti, Joseph
    Tamari, Roni
    Mattila, Deborah
    Mussetter, Alisha
    Bruzauskas, Ruta
    Chen, Min
    Leckrone, Erin
    Myers, Judith
    Mau, Lih-Wen
    Rizzo, J. Douglas
    Saber, Wael
    Horowitz, Mary
    Lee, Stephanie J.
    Burns, Linda J.
    Shaw, Bronwen E.
    TRANSPLANTATION AND CELLULAR THERAPY, 2022, 28 (02): : 112.e1 - 112.e9
  • [4] Feasibility test of a UK-scalable electronic system for regular collection of patient-reported outcome measures and linkage with clinical cancer registry data: The electronic Patient-reported Outcomes from Cancer Survivors (ePOCS) system
    Ashley, Laura
    Jones, Helen
    Forman, David
    Newsham, Alex
    Brown, Julia
    Downing, Amy
    Velikova, Galina
    Wright, Penny
    BMC MEDICAL INFORMATICS AND DECISION MAKING, 2011, 11
  • [5] Feasibility test of a UK-scalable electronic system for regular collection of patient-reported outcome measures and linkage with clinical cancer registry data: The electronic Patient-reported Outcomes from Cancer Survivors (ePOCS) system
    Laura Ashley
    Helen Jones
    David Forman
    Alex Newsham
    Julia Brown
    Amy Downing
    Galina Velikova
    Penny Wright
    BMC Medical Informatics and Decision Making, 11
  • [6] "Routine assessment of patient-reported outcomes (PROs) in patients with multiple myeloma" An analysis of the Austrian Myeloma Registry (AMR)
    Weger, R.
    Willenbacher, W.
    Loth, F.
    Willenbacher, E.
    Blazek, T.
    ONCOLOGY RESEARCH AND TREATMENT, 2016, 39 : 159 - 159
  • [7] The Progress Tracker Breast Cancer Registry: Feasibility of a longitudinal patient-led, patient-reported outcomes (PROM) registry
    Leduc, Shaniah
    Gibson, Amanda Williams
    Dean, Michelle Liane
    Carson, Kimberly
    Khan, Omar Farooq
    Howell, Doris
    JOURNAL OF CLINICAL ONCOLOGY, 2024, 42 (16)
  • [8] Feasibility and utilization of electronic patient-reported outcome measures for lung cancer in routine clinical care
    Basch, Ethan
    Lin, Huamao Mark
    Cala, Mary Lynn
    Styliadou, Melpomeni
    Galaznik, Aaron
    Wujcik, Debra
    Rusli, Emelly
    Coombs, Nicholas C.
    Beamon, Emily R.
    JOURNAL OF CLINICAL ONCOLOGY, 2024, 42 (16)
  • [9] Bravenet Launches Patient-Reported Outcomes Registry
    Horrigan, Bonnie J.
    EXPLORE-THE JOURNAL OF SCIENCE AND HEALING, 2013, 9 (03) : 128 - 130
  • [10] Evaluation of electronic patient-reported outcome assessment in inpatient cancer care: a feasibility study
    Salm, Hanna
    Hentschel, Leopold
    Eichler, Martin
    Pink, Daniel
    Fuhrmann, Stephan
    Kramer, Michael
    Reichardt, Peter
    Schuler, Markus K.
    SUPPORTIVE CARE IN CANCER, 2023, 31 (10)